Literatur
-
1
Somerville K W, Logan R F, Edmond M, Langman M J.
Smoking
and Crohn’s disease.
Br Med J.
1984;
289
954-956
-
2
Harries A D, Baird A, Rhodes J.
Non-smoking:
a feature of ulcerative colitis.
Br Med J.
1982;
284
706
-
3
Malchow H.
Nikotin
und Colitis ulcerosa.
Dtsch Med Wochenschr.
1987;
112
1476
-
4
Thomas G A, Rhodes J, Green J T.
Inflammatory
bowel disease and smoking - a review.
Am J Gastroenterol.
1998;
93
144-149
-
5
Sandborn W J.
Nicotine
therapy for ulcerative colitis: a review of rationale, mechanisms,
pharmacology, and clinical results.
Am J Gastroenterol.
1999;
94
1161-1171
-
6
Bridger S, Lee J C, Bjarnason I, Jones J E, Macpherson A J.
In siblings with similar genetic susceptibility
for inflammatory bowel disease, smokers tend to develop Crohn’s
disease and non-smokers develop ulcerative colitis.
Gut.
2002;
51
21-25
-
7
Van Erpecum K J, Smits S J, van de Meeberg P C, Linn F H, Wolfhagen F H, van Berge-Henegouwen G P, Algra A.
Risk
of primary sclerosing cholangitis is associated with nonsmoking
behavior.
Gastroenterology.
1996;
110
1503-1506
-
8
Loftus E V
Jr, Sandborn W J, Tremaine W J, Mahoney D W, Zinsmeister A R, Offord K P, Melton L J.
Primary
sclerosing cholangitis is associated with nonsmoking: a case- con-trol
study.
Gastroenterology.
1996;
110
1496-1502
-
9
Angulo P, Bharucha A E, Jorgensen R A, DeSotel C K, Sandborn W J, Larusso N F, Lindor K D.
Oral nicotine
in treatment of primary sclerosing cholangitis: a pilot study.
Dig
Dis Sci.
1999;
44
602-607
-
10
Vleggaar F P, van Buuren H R, van Berge
Henegouwen G P, Hop W C, van Erpecum K J.
No beneficial
effects of transdermal nicotine in patients with primary sclerosing
cholangitis: results of a randomized double-blind placebo-controlled
cross-over study.
Eur J Gastroenterol Hepatol.
2001;
13
171-175
-
11
Jick H, Walker A M.
Cigarette smoking
and ulcerative colitis.
N Engl J Med.
1983;
308
261-263
-
12
Odes H S, Fich A, Reif S, Halak A, Lavy A, Keter D, Eliakim R, Paz J, Broide E, Niv Y, Ron Y, Villa Y, Arber N, Gilat T.
Effects
of current cigarette smoking on clinical course of Crohn’s
disease and ulcerative colitis.
Dig Dis Sci.
2001;
46
1717-1721
-
13
Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre J P, Cosnes J.
Impact of cessation of smoking
on the course of ulcerative colitis.
Am J Gastroenterol.
2001;
96
2113-2116
-
14
Holt P G.
Immune
and inflammatory function in cigarette smokers.
Thorax.
1987;
42
241-249
-
15
Ginns L C, Miller L G, Goldenheim P D, Goldstein G, Bria W F.
Alterations in immunoregulatory
cells in lung cancer and smoking.
J Clin Immunol.
1982;
2
90S-94S
-
16
Madretsma G S, Donze G J, van Dijk A P, Tak C J, Wilson J H, Zijlstra F J.
Nicotine
inhibits the in vitro production of interleukin 2 and tumour necrosis
factor-a by human mononuclear cells.
Immunopharmacology.
1996;
35
47-51
-
17
Madretsma S, Wolters L M, van Dijk J P, Tak C J, Feyerabend C, Wilson J H, Zijlstra F J.
In-vivo effect of nicotine on
cytokine production by human non-adherent mononuclear cells.
Eur
J Gastroenterol Hepatol.
1996;
8
1017-1020
-
18
Van Dijk A P, Meijssen M A, Brouwer A J, Hop W C, van
Bergeijk J D, Feyerabend C, Wilson J H, Zijlstra F J.
Transdermal nicotine inhibits interleukin
2 synthesis by mononuclear cells derived from healthy volunteers.
Eur
J Clin Invest.
1998;
28
664-671
-
19
Motley R J, Rhodes J, Williams G, Tavares I A, Bennett A.
Smoking,
eicosanoids and ulcerative colitis.
J Pharm Pharmacol.
1990;
42
288-289
-
20
Zijlstra F J, Srivastava E D, Rhodes M, van Dijk A P, Fogg F, Samson H J, Copeman M, Russell M A, Feyerabend C, Williams G T. et
al .
Effect of nicotine on rectal mucus and mucosal
eicosanoids.
Gut.
1994;
35
247-251
-
21
Lashner B A, Hanauer S B, Silverstein M D.
Testing nicotine gum for ulcerative
colitis patients. Experience with single-patient trials.
Dig
Dis Sci.
1990;
35
827-832
-
22
Pullan R D, Rhodes J, Ganesh S, Mani V, Morris J S, Williams G T, Newcombe R G, Russell M A, Feyerabend C, Thomas G A. et
al .
Transdermal nicotine for active ulcerative colitis.
N
Engl J Med.
1994;
330
811-815
-
23
Thomas G A, Rhodes J, Mani V, Williams G T, Newcombe R G, Russell M A, Feyerabend C.
Transdermal nicotine as maintenance therapy
for ulcerative colitis.
N Engl J Med.
1995;
332
988-992
-
24
Thomas G A, Rhodes J, Ragunath K, Mani V, Williams G T, Newcombe R G, Russell M A, Feyerabend C.
Transdermal
nicotine compared with oral prednisolone therapy for active ulcerative
colitis.
Eur J Gastroenterol Hepatol.
1996;
8
769-776
-
25
Sandborn W J, Tremaine W J, Offord K P, Lawson G M, Petersen B T, Batts K P, Croghan I T, Dale L C, Schroeder D R, Hurt R D.
Transdermal nicotine for mildly
to moderately active ulcerative colitis. A randomized, double-blind,
placebo-controlled trial.
Ann Intern Med.
1997;
126
364-371
-
26
Guslandi M, Tittobello A.
Outcome of ulcerative
colitis after treatment with transdermal nicotine.
Eur
J Gastroenterol Hepatol.
1998;
10
513-515
-
27
Konsensuskonferenz der
DGVS.
Diagnostik und Therapie der Colitis ulcerosa.
Z
Gastroenterol.
2001;
39
19-70
Autoren
Dr. C. G. Dietrich
PD Dr. F. Lammert
Prof. Dr. S Matern
Medizinische
Klinik III, Universitätsklinikum der RWTH
Pauwelsstr.
30
52074 Aachen
